Related Experiment Video
Updated: Jul 16, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Spasmolytische wirkung des isoasaronfreien kalmus1
K Keller1, K P Odenthal, E Leng-Peschlow
1Retzgrubenweg 12, D-5500 Trier, W. Germany.
Abstract:
ACORUS CALAMUS yields different drug types with varying content of beta-asarone, a substance which proved to be carcinogetic in rats. We tested essential oils with different beta-asarone content for their activity against histatnine-spasms in the isolated guinea pig ileum. At a dose level of 10 microg/cm (3), the beta-asarone-free oil (type I) had a pronounced, spasmolytic activity which was comparable to that of the antihistaminic drug pyrilaminemaleate used as a standard antagonist (4 microg/cm (3). Each of these drugs changed the EC (50) for histamine from 29 microg/cm (3) to 118 microg/cm (3) approximately. At a dose level of 10 microg/cm (3) the beta-asarone-rich oil (type IV) showed no spasmolytic activity at all. The essential oil of the european calamus with low content of beta-asarone (type II) had also a good spasmolytic effect, however inferior to that of the beta-asarone-free oil, so that the above cited decrease of the EC (50) value of histamine could be seen in a concentration of 32 microg/cm (3). For this reasons and for better drug-safety, only the rhizomas of the beta-asarone-free diploid or of the triploid calamus with low content of beta-asarone should be used.
Related Concept Videos
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Skeletal Muscle Relaxants: Therapeutic Uses
